These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6491905)

  • 41. Supercritical fluid assisted production of micrometric powders of the labile trypsin and chitosan/trypsin composite microparticles.
    Shen YB; Guan YX; Yao SJ
    Int J Pharm; 2015 Jul; 489(1-2):226-36. PubMed ID: 25957701
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel in situ forming drug delivery system for controlled parenteral drug delivery.
    Kranz H; Bodmeier R
    Int J Pharm; 2007 Mar; 332(1-2):107-14. PubMed ID: 17084049
    [TBL] [Abstract][Full Text] [Related]  

  • 43. On the design of in situ forming biodegradable parenteral depot systems based on insulin loaded dialkylaminoalkyl-amine-poly(vinyl alcohol)-g-poly(lactide-co-glycolide) nanoparticles.
    Packhaeuser CB; Kissel T
    J Control Release; 2007 Nov; 123(2):131-40. PubMed ID: 17854938
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel and simple preparation method of matrix-type composite particles for controlled drug release by mechanical action.
    Kondo S; Sasai Y; Kosaki M; Kuzuya M
    Chem Pharm Bull (Tokyo); 2004 Apr; 52(4):488-9. PubMed ID: 15056974
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polymer microspheres for controlled drug release.
    Freiberg S; Zhu XX
    Int J Pharm; 2004 Sep; 282(1-2):1-18. PubMed ID: 15336378
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The impact of the injection mold temperature upon polymer crystallization and resulting drug release from immediate and sustained release tablets.
    Van Renterghem J; Dhondt H; Verstraete G; De Bruyne M; Vervaet C; De Beer T
    Int J Pharm; 2018 Apr; 541(1-2):108-116. PubMed ID: 29409747
    [TBL] [Abstract][Full Text] [Related]  

  • 47. pH-sensitive micelles self-assembled from polymer brush (PAE-
    Huang X; Liao W; Zhang G; Kang S; Zhang CY
    Int J Nanomedicine; 2017; 12():2215-2226. PubMed ID: 28356738
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Controlling the Release of Indomethacin from Glass Solutions Layered with a Rate Controlling Membrane Using Fluid-Bed Processing. Part 1: Surface and Cross-Sectional Chemical Analysis.
    Dereymaker A; Scurr DJ; Steer ED; Roberts CJ; Van den Mooter G
    Mol Pharm; 2017 Apr; 14(4):959-973. PubMed ID: 28206770
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Applications of ethylene vinyl acetate copolymers (EVA) in drug delivery systems.
    Schneider C; Langer R; Loveday D; Hair D
    J Control Release; 2017 Sep; 262():284-295. PubMed ID: 28789964
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Unintended potential impact of perfect sink conditions on PLGA degradation in microparticles.
    Klose D; Delplace C; Siepmann J
    Int J Pharm; 2011 Feb; 404(1-2):75-82. PubMed ID: 21056644
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sustained release from hot-melt extruded matrices based on ethylene vinyl acetate and polyethylene oxide.
    Almeida A; Brabant L; Siepmann F; De Beer T; Bouquet W; Van Hoorebeke L; Siepmann J; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2012 Nov; 82(3):526-33. PubMed ID: 22986082
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Critical factors in the release of drugs from sustained release hydrophilic matrices.
    Maderuelo C; Zarzuelo A; Lanao JM
    J Control Release; 2011 Aug; 154(1):2-19. PubMed ID: 21497624
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization and dynamic mechanical analysis of selective laser sintered hydroxyapatite-filled polymeric composites.
    Zhang Y; Hao L; Savalani MM; Harris RA; Tanner KE
    J Biomed Mater Res A; 2008 Sep; 86(3):607-16. PubMed ID: 18022838
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Encapsulated hydrophilic polymer beads containing indomethacin as controlled release drug delivery systems.
    Suryakusuma H; Jun HW
    J Pharm Pharmacol; 1984 Aug; 36(8):497-501. PubMed ID: 6148389
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Formulation of a poorly water-soluble drug in sustained-release hollow granules with a high viscosity water-soluble polymer using a fluidized bed rotor granulator.
    Asada T; Yoshihara N; Ochiai Y; Kimura SI; Iwao Y; Itai S
    Int J Pharm; 2018 Apr; 541(1-2):246-252. PubMed ID: 29496456
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Poly(ethylene-co-vinyl acetate) copolymer matrix for delivery of chlorhexidine and acyclovir drugs for use in the oral environment: effect of drug combination, copolymer composition and coating on the drug release rate.
    Tallury P; Alimohammadi N; Kalachandra S
    Dent Mater; 2007 Apr; 23(4):404-9. PubMed ID: 16556460
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Macromolecule release from monodisperse PLG microspheres: control of release rates and investigation of release mechanism.
    Berkland C; Pollauf E; Raman C; Silverman R; Kim K'; Pack DW
    J Pharm Sci; 2007 May; 96(5):1176-91. PubMed ID: 17455338
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Poly(ether-anhydride) dry powder aerosols for sustained drug delivery in the lungs.
    Fiegel J; Fu J; Hanes J
    J Control Release; 2004 May; 96(3):411-23. PubMed ID: 15120898
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biocompatible controlled release polymers for delivery of polypeptides and growth factors.
    Langer R; Moses M
    J Cell Biochem; 1991 Apr; 45(4):340-5. PubMed ID: 2045427
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Controlled release from drug microparticles via solventless dry-polymer coating.
    Capece M; Barrows J; Davé RN
    J Pharm Sci; 2015 Apr; 104(4):1340-51. PubMed ID: 25589332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.